Ann: Imugene onCARlytics Doses First Patient in IV Combination, page-205

Ragnaroff,

I made a mistake in my previous reply. When I posted 2 weeks between dosing. That came from a video with YF discussing the early Vaxinia Combo trials. However the main thrust I wanted to address was the enormous effort taken to design and get FDA approvals.

As for my , Mr Positive, attitude, I can only go on the evidence. The shareprice is a different subject to the progressing science. I never let that interfere with my assessment of my underlying investment analysis. I do refer to it when deploying my capital. Which is why I have been adding to my position over the last few weeks.

At this point in time we are months away from finding out whether we have shares in the next NVIDIA or if we’ve bought a duster.
I’ll refer back to Leslie’s comments on the data. And Yuman’s explanation of the science.